On Monday, Teva- Pharmaceutical Industries Ltd. ADR (NYSE: TEVA) was 2.44% up from the session before settling in for the closing price of $32.01. A 52-week range for TEVA has been $12.47 – $32.91.
Over the past five-year period, the drop rate of yearbook sales for the company of the Healthcare sector was -9.65%. When this article was written, the company’s average yearly earnings per share was at 5.67%. With a float of $1.14 billion, this company’s outstanding shares have now reached $1.15 billion.
Teva- Pharmaceutical Industries Ltd. ADR (TEVA) Insider Activity
Also, it is sometimes useful to examine the sentiment of large-scale investors toward Teva- Pharmaceutical Industries Ltd. ADR stocks. The insider ownership of Teva- Pharmaceutical Industries Ltd. ADR is 0.16%, while institutional ownership is 57.75%. The most recent insider transaction that took place on Dec 16 ’25, was worth 371,504. In this transaction Chief Accounting Officer of this company sold 12,300 shares at a rate of $30.20, taking the stock ownership to the 5,650 shares. Before that another transaction happened on Dec 16 ’25, when Company’s Director sold 77,400 for $30.24, making the entire transaction worth $2,340,646. This insider now owns 367,600 shares in total.
Teva- Pharmaceutical Industries Ltd. ADR (TEVA) Earnings and Forecasts
Going through the last 3-months fiscal report unveiled on the 12/31/2024, it has been observed that the corporation posted 0.71 earnings per share (EPS) during the time that was better than consensus figure (set at 0.7) by 0.01. Wall Street market experts anticipate that the next fiscal year will bring earnings of 0.59 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 5.67% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 7.44% during the next five years compared to -9.65% drop over the previous five years of trading.
Teva- Pharmaceutical Industries Ltd. ADR (NYSE: TEVA) Trading Performance Indicators
You can see what Teva- Pharmaceutical Industries Ltd. ADR (TEVA) is doing with its current performance indicators. In the most recent quarter, the stock posted a quick ratio of 0.82. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 2.23. Likewise, its price to free cash flow for the trailing twelve months is 149.71.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is 0.61, a number that is poised to hit 0.64 in the next quarter and is forecasted to reach 2.76 in one year’s time.
